PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Frontiers in Immunology0 citationsOpen Access

CITED2: a novel hub gene downregulated in Hashimoto’s thyroiditis and associated with M1 macrophages via bioinformatics analysis and clinical validation

XBXuefeng BaiHDHonghong DuanYXYan Xu

Key Points

  • This study aims to identify key genes involved in thyroid tissue damage in Hashimoto's thyroiditis, focusing on macrophage regulation.
  • Performed bulk RNA-seq analysis comparing thyroid tissues from Hashimoto's thyroiditis patients and normal controls.
  • Conducted differential gene expression and functional enrichment analyses.
  • Constructed protein-protein interaction (PPI) networks and analyzed immune cell infiltration using CIBERSORT.
  • Validated findings with qRT-PCR, Western blotting, and immunohistochemistry in an independent cohort.
  • Identified 1,752 unique differentially expressed genes related to Hashimoto's thyroiditis.
  • Confirmed 10 down-regulated hub genes, including CITED2, with a significant increase in M1 macrophages.
  • Demonstrated a strong negative correlation between CITED2 mRNA and M1 macrophage abundance.
  • Clinical validation confirmed the suppression of CITED2 at both mRNA and protein levels in thyroid tissues.

Abstract

Objective This study aims to define the core transcriptomic signatures of thyroid tissue damage in Hashimoto’s thyroiditis (HT), with a specific focus on identifying regulatory hub genes critical for macrophage polarization. Methods We performed an integrated analysis of bulk RNA-seq data from a public dataset (GEO: GSE165724), comparing thyroid tissues from HT patients with those from normal controls. The bioinformatic analysis included differential gene expression analysis, functional enrichment analysis, protein-protein interaction (PPI) network construction, and immune cell infiltration profiling using CIBERSORT. Key findings were experimentally validated in an independent clinical cohort (n=32) using quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, and immunohistochemistry (IHC). Results Our analysis identified a core set of 1,752 HT-specific unique differentially expressed genes (DEGs). Network analysis distilled these to 5 up-regulated (e.g., IFNG, CD4, PTPRC) and 10 down-regulated hub genes (e.g., CITED2, TXN2, FOXA2). The immune landscape in HT tissues was markedly remodeled, featuring a significant increase in M1 macrophages. Correlation analysis revealed that IFNG mRNA positively correlated with M1 abundance, whereas CITED2 mRNA showed a strong negative correlation. Clinical validation confirmed significant IFNG upregulation and CITED2 downregulation at the mRNA level. At the protein level, validation demonstrated a significant suppression of CITED2 in HT tissues. IHC co-localization analysis specifically indicated markedly weakened CITED2 expression in the cytoplasm and nucleus of thyroid follicular cells (TFCs) from HT patients. Furthermore, M1 macrophage markers (CD80/CD86) were significantly elevated and positively correlated with autoantibody levels and IFNG mRNA expression, but inversely correlated with CITED2. Conclusions This study defines a robust transcriptomic and immune signature for HT. The significant downregulation of CITED2, specifically within thyroid follicular cells, and its inverse correlation with M1 macrophages, imply that its suppression may disrupt thyroid follicular cell function and contribute to the pro-inflammatory immune microenvironment, thereby revealing a novel potential mechanism in HT pathogenesis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bai et al. (2026) studied this question.

synapsesocial.com/papers/69a285aa0a974eb0d3c00aa6https://doi.org/10.3389/fimmu.2026.1764100
Ask AI
Helpful
Bookmark
Share
View Full Paper